What is iView Therapeutics worth?
$107.4Mlast known valuation
iView Therapeutics last raised $9.2M in its Early Stage VC (May 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for iView Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Early Stage VC | $9.2M | ▮ | ▮ |
| Feb 2021 | Early Stage VC | $30.0M | ▮ | ▮ |
How iView Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For iView Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is iView Therapeutics worth?
- iView Therapeutics's last known valuation is $107.4M.
- How much has iView Therapeutics raised?
- iView Therapeutics has raised $39.2M in total funding across 2 recorded rounds.
- When did iView Therapeutics last raise?
- iView Therapeutics last raised in May 2024 (Early Stage VC), raising $9.2M.